Detection of HPV DNA in Saliva of Patients with HPV-Associated Oropharyngeal Cancer Treated with Radiotherapy
Current Oncology · 2024
DOI: 10.3390/curroncol31080328 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2024. Verfasst von Atsushi Motegi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa 277-8577, Japan. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Saliva, DNA, Viral, Papillomavirus Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, National Cancer Center Research and Development Fund, JSPS KAKENHI.
Abstract (Originalsprache)
Background
To investigate the technical feasibility of RT–PCR and direct sequencing to quantify HPV DNA in the saliva of patients with Human-Papilloma-Virus related oropharyngeal cancer (HPV-OPC), the level of which is known to predict prognosis after treatment.
Methods
Nine patients with locally advanced HPV-OPC treated with definitive radiotherapy with chemotherapy or cetuximab, or radiotherapy alone between April 2016 and September 2017, were enrolled, two of whom also received induction chemotherapy. Saliva was collected before (baseline), during (mid-RT) and after (post-RT) radiotherapy. HPV-16 DNAs (E6 and E7) in saliva were quantified by RT–PCR and sequencing, the latter using a custom cancer panel. Correlations between HPV DNA levels and clinical outcomes were assessed.
Results
Compared to the baseline, the relative cycle threshold (Ct) value of E6 and E7 reduced at the point of mid-RT in the majority of the patients (100% and 75% for E6 and E7, respectively). Similarly, the relative Ct value from the baseline to post-RT reduced in 86% and 100% of the patients for E6 and E7, respectively. During the follow-up period, three patients (33%) experienced disease progression. The relative baseline Ct values of these three patients were in the top 4 of all the patients. The sequences of HPV DNA were detected in five (83%) of six samples of the baseline saliva that underwent DNA sequencing, along with several gene mutations, such as TP53,CDKN2A and PIK3CA.
Conclusions
This study demonstrates that, in addition to detection and quantification of HPV DNA by RT–PCR, detection by sequencing of HPV-DNA using a customized cancer panel is technically possible.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa 277-8577, Japan.
- Division of Radiation Oncology and Particle Therapy, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwa 277-8577, Japan.
- Department of Translational Informatics, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwa 277-8577, Japan.
- Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa 277-8577, Japan.
- Department of Head and Neck Surgery, National Cancer Center Hospital East, Kashiwa 277-8577, Japan.
ORCID-Profile: Masaki Nakamura, Makoto Tahara
Förderung
- Japan Society for the Promotion of Science
- National Cancer Center Research and Development Fund
- JSPS KAKENHI
Zitieren
APA
Motegi, A., Kageyama, S. I., Kashima, Y., Hirata, H., Hojo, H., Nakamura, M., Fujisawa, T., Enokida, T., Tahara, M., Matsuura, K., & Zenda, S. (2024). Detection of HPV DNA in Saliva of Patients with HPV-Associated Oropharyngeal Cancer Treated with Radiotherapy. Current Oncology. https://doi.org/10.3390/curroncol31080328
Vancouver
Motegi A, Kageyama SI, Kashima Y, Hirata H, Hojo H, Nakamura M, et al. Detection of HPV DNA in Saliva of Patients with HPV-Associated Oropharyngeal Cancer Treated with Radiotherapy. Current Oncology. 2024. doi:10.3390/curroncol31080328
BibTeX
@article{Motegi2024,
author = {Motegi, Atsushi and Kageyama, Shun-Ichiro and Kashima, Yukie and Hirata, Hidenari and Hojo, Hidehiro and Nakamura, Masaki and Fujisawa, Takeshi and Enokida, Tomohiro and Tahara, Makoto and Matsuura, Kazuto and Zenda, Sadamoto},
title = {Detection of HPV DNA in Saliva of Patients with HPV-Associated Oropharyngeal Cancer Treated with Radiotherapy},
journal = {Current Oncology},
year = {2024},
doi = {10.3390/curroncol31080328}
}
EUVIMED